Back

Clinical effects of metoprolol in obstructive hypertrophic cardiomyopathy (TEMPO). A randomized, double-blinded, placebo-controlled crossover trial

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Myocardial and pericardial disease e-posters Hypertrophic Cardiomyopathy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Mrs Anne Dybro

Aarhus University Hospital, Aarhus (Denmark)

93 More presentations in this session

Presentation thumbnail
Combination of arrhythmogenic right ventricular dysplasia with left ventricular non-compaction as a special form of cardiomyopathy: clinic, diagnostics, genetic, natural course
Professor O. Blagova (Moscow, RU)
Abstract Slides
Presentation thumbnail
Efficacy and safety of alcohol septal ablation in adolescents and young adults with symptomatic hypertrophic obstructive cardiomyopathy
Doctor D. Lawin (Bielefeld, DE)
Abstract Slides
Presentation thumbnail
Cardiac rupture - the most serious complication of takotsubo syndrome
Doctor M. Zalewska-Adamiec (Bialystok, PL)
Abstract Slides
Presentation thumbnail
Noncompact myocardium with dilated phenotype: differences in comparison with other forms of dilated cardiomyopathy..
Professor O. Blagova (Moscow, RU)
Abstract Slides
Presentation thumbnail
Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA in patients with hypertrophic cardiomyopathy
Doctor A. Trongtorsak (Evanston, US)
Abstract Slides

Access the full session

Session thumbnail
Myocardial and pericardial disease e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources